Aenova Group GmbH
Aenova Group GmbH, a leading contract development and manufacturing organisation (CDMO), is headquartered in Germany and operates extensively across Europe and North America. Founded in 2011, Aenova has rapidly established itself in the pharmaceutical and healthcare sectors, specialising in the production of solid dosage forms, including tablets and capsules, as well as innovative drug delivery systems. The company is renowned for its commitment to quality and compliance, offering a comprehensive range of services from formulation development to commercial manufacturing. Aenova's state-of-the-art facilities and advanced technologies enable it to meet the diverse needs of its clients, ensuring efficient and reliable production processes. With a strong market position, Aenova Group GmbH continues to achieve significant milestones, solidifying its reputation as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Aenova Group GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aenova Group GmbH's score of 15 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aenova Group GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. The company is identified as a merged entity, with emissions performance data inherited from its parent company, Aenova Holding GmbH. However, no specific figures or reduction targets have been disclosed. As part of its climate commitments, Aenova Group GmbH has not outlined any specific reduction initiatives or targets, including those aligned with the Science Based Targets initiative (SBTi). The absence of detailed emissions data and reduction strategies suggests that the company may still be in the early stages of formalising its climate action plans. In the context of the pharmaceutical and healthcare industry, where Aenova operates, there is an increasing emphasis on sustainability and carbon footprint reduction. Companies in this sector are often encouraged to adopt comprehensive climate strategies to mitigate their environmental impact. Aenova Group GmbH's future commitments and initiatives will be crucial in aligning with industry standards and expectations for climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aenova Group GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
